Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood Advances. “This is one of the first large, real-world, long-term studies to assess the efficacy of hydroxyurea outside of a controlled setting,” said study author Paul George, MD, … Read more
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke. However, new research from Emory University may revolutionize how clinicians understand and treat these harmful blood clots, or thrombi, a byproduct of a condition called thromboinflammation. In a groundbreaking study published in Nature, researchers have discovered the potential to … Read more
Harnessing the Power of CRISPR in Regenerative Medicine: A Comprehensive Look In recent years, CRISPR/Cas9 technologies have emerged as groundbreaking tools in the rapidly evolving field of regenerative… The post Revolutionizing Regenerative Medicine: The Advancements and Potential of CRISPR Technologies in Tissue Repair and Disease Treatment appeared first on NewsyList. Source link